信函：环孢素和维多珠单抗治疗激素难治性溃疡性结肠炎 - Suppr

Suppr

超能文献

Letter: ciclosporin and vedolizumab for steroid-refractory ulcerative colitis.

作者信息

Resál Tamás, Pigniczki Daniella, Szántó Kata, Rutka Mariann, Farkas Klaudia, Molnar Tamas

机构信息

First Department of Medicine, University of Szeged Faculty of Medicine, Szeged, Hungary.

Surgery Department, University of Szeged Faculty of Medicine, Szeged, Hungary.

出版信息

Aliment Pharmacol Ther. 2020 Aug;52(3):578-579. doi: 10.1111/apt.15896.

DOI:10.1111/apt.15896

PMID:32656847

Abstract

摘要

相似文献

Letter: ciclosporin and vedolizumab for steroid-refractory ulcerative colitis.

Aliment Pharmacol Ther. 2020 Aug;52(3):578-579. doi: 10.1111/apt.15896.

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):494-501. doi: 10.1016/j.cgh.2018.08.081. Epub 2018 Sep 10.

Risk Factors of Colectomy in Patients With Refractory Ulcerative Colitis Under Calcineurin Inhibitors Combined With Vedolizumab.

Clin Gastroenterol Hepatol. 2019 May;17(6):1213-1214. doi: 10.1016/j.cgh.2018.12.004.

Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):486-493. doi: 10.1016/j.cgh.2018.04.060. Epub 2018 May 8.

Editorial: calcineurin inhibitors as a bridge to vedolizumab for severe ulcerative colitis.

Aliment Pharmacol Ther. 2020 Mar;51(6):663-664. doi: 10.1111/apt.15632.

Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis.

Aliment Pharmacol Ther. 2002 Dec;16(12):2061-5. doi: 10.1046/j.1365-2036.2002.01385.x.

Short- and long-term efficacy of adalimumab salvage therapy after failure of calcineurin inhibitors in steroid-refractory ulcerative colitis.

Scand J Gastroenterol. 2018 Oct-Nov;53(10-11):1236-1244. doi: 10.1080/00365521.2018.1511825. Epub 2018 Oct 24.

Pharmacodynamic assessment of vedolizumab for the treatment of ulcerative colitis.

Expert Opin Drug Metab Toxicol. 2016 Jul;12(7):833-42. doi: 10.1080/17425255.2016.1181171. Epub 2016 May 12.

Low-dose oral microemulsion ciclosporin for severe, refractory ulcerative colitis.

Aliment Pharmacol Ther. 2005 Aug 1;22(3):203-8. doi: 10.1111/j.1365-2036.2005.02552.x.

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.

Lancet. 2012 Dec 1;380(9857):1909-15. doi: 10.1016/S0140-6736(12)61084-8. Epub 2012 Oct 10.

引用本文的文献

Steroid-Refractory Acute Severe Ulcerative Colitis in Infliximab-Experienced Patients.

GE Port J Gastroenterol. 2024 Mar 21;31(5):314-324. doi: 10.1159/000537693. eCollection 2024 Oct.

What to do when traditional rescue therapies fail in acute severe ulcerative colitis.

Intest Res. 2024 Oct;22(4):397-413. doi: 10.5217/ir.2024.00003. Epub 2024 May 16.

An Old Bridge to the Newer Biologics: Cyclosporine for Rescue Therapy in Acute Severe Ulcerative Colitis.

Dig Dis Sci. 2022 Dec;67(12):5439-5443. doi: 10.1007/s10620-022-07682-7. Epub 2022 Sep 20.

A Practical Clinical Approach to the Management of High-Risk Ulcerative Colitis.

Gastroenterol Hepatol (N Y). 2021 Feb;17(2):59-66.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Letter: ciclosporin and vedolizumab for steroid-refractory ulcerative colitis.

Aliment Pharmacol Ther. 2020 Aug;52(3):578-579. doi: 10.1111/apt.15896.

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):494-501. doi: 10.1016/j.cgh.2018.08.081. Epub 2018 Sep 10.

Risk Factors of Colectomy in Patients With Refractory Ulcerative Colitis Under Calcineurin Inhibitors Combined With Vedolizumab.

Clin Gastroenterol Hepatol. 2019 May;17(6):1213-1214. doi: 10.1016/j.cgh.2018.12.004.

Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):486-493. doi: 10.1016/j.cgh.2018.04.060. Epub 2018 May 8.

Editorial: calcineurin inhibitors as a bridge to vedolizumab for severe ulcerative colitis.

Aliment Pharmacol Ther. 2020 Mar;51(6):663-664. doi: 10.1111/apt.15632.

Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis.

Aliment Pharmacol Ther. 2002 Dec;16(12):2061-5. doi: 10.1046/j.1365-2036.2002.01385.x.

Short- and long-term efficacy of adalimumab salvage therapy after failure of calcineurin inhibitors in steroid-refractory ulcerative colitis.

Scand J Gastroenterol. 2018 Oct-Nov;53(10-11):1236-1244. doi: 10.1080/00365521.2018.1511825. Epub 2018 Oct 24.

Pharmacodynamic assessment of vedolizumab for the treatment of ulcerative colitis.

Expert Opin Drug Metab Toxicol. 2016 Jul;12(7):833-42. doi: 10.1080/17425255.2016.1181171. Epub 2016 May 12.

Low-dose oral microemulsion ciclosporin for severe, refractory ulcerative colitis.

Aliment Pharmacol Ther. 2005 Aug 1;22(3):203-8. doi: 10.1111/j.1365-2036.2005.02552.x.

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.

Lancet. 2012 Dec 1;380(9857):1909-15. doi: 10.1016/S0140-6736(12)61084-8. Epub 2012 Oct 10.

引用本文的文献

Steroid-Refractory Acute Severe Ulcerative Colitis in Infliximab-Experienced Patients.

GE Port J Gastroenterol. 2024 Mar 21;31(5):314-324. doi: 10.1159/000537693. eCollection 2024 Oct.

What to do when traditional rescue therapies fail in acute severe ulcerative colitis.

Intest Res. 2024 Oct;22(4):397-413. doi: 10.5217/ir.2024.00003. Epub 2024 May 16.

An Old Bridge to the Newer Biologics: Cyclosporine for Rescue Therapy in Acute Severe Ulcerative Colitis.

Dig Dis Sci. 2022 Dec;67(12):5439-5443. doi: 10.1007/s10620-022-07682-7. Epub 2022 Sep 20.

A Practical Clinical Approach to the Management of High-Risk Ulcerative Colitis.

Gastroenterol Hepatol (N Y). 2021 Feb;17(2):59-66.

Letter: ciclosporin and vedolizumab for steroid-refractory ulcerative colitis.

作者信息

Resál Tamás, Pigniczki Daniella, Szántó Kata, Rutka Mariann, Farkas Klaudia, Molnar Tamas

机构信息

First Department of Medicine, University of Szeged Faculty of Medicine, Szeged, Hungary.

Surgery Department, University of Szeged Faculty of Medicine, Szeged, Hungary.

出版信息

Aliment Pharmacol Ther. 2020 Aug;52(3):578-579. doi: 10.1111/apt.15896.

DOI:10.1111/apt.15896

PMID:32656847

Abstract

摘要